59892-37-4 Usage
Uses
Used in Pharmaceutical Research:
1-(2,3,5-Tribenzoyl--D-ribofuranosyl)-5-nitropyridine-2(1H)-one is used as a research compound for exploring its potential in the development of new pharmaceutical agents. Its unique structure and functional groups may offer novel interactions with biological targets, potentially leading to the discovery of new therapeutics.
Used in Drug Development:
In the drug development industry, 1-(2,3,5-Tribenzoyl--D-ribofuranosyl)-5-nitropyridine-2(1H)-one is used as a lead compound for the design and synthesis of new drugs. Its complex structure may provide a foundation for the creation of molecules with specific biological activities, targeting various diseases and conditions.
Used in Chemical Synthesis:
1-(2,3,5-Tribenzoyl--D-ribofuranosyl)-5-nitropyridine-2(1H)-one is utilized as a synthetic building block in the chemical synthesis of more complex molecules. Its versatile structure allows for further functionalization and modification, enabling the development of a diverse range of chemical products with potential applications in various fields.
Check Digit Verification of cas no
The CAS Registry Mumber 59892-37-4 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 5,9,8,9 and 2 respectively; the second part has 2 digits, 3 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 59892-37:
(7*5)+(6*9)+(5*8)+(4*9)+(3*2)+(2*3)+(1*7)=184
184 % 10 = 4
So 59892-37-4 is a valid CAS Registry Number.
59892-37-4Relevant academic research and scientific papers
Synthesis of N3,5′-cyclo-4-(β-D-ribofuranosyl)-vic- triazolo[4,5-b]pyridin-5-one and its 3′-deoxysugar analogue as potential anti-hepatitis C virus agents
Wang, Peiyuan,Hollecker, Laurent,Pankiewicz, Krzysztof W.,Patterson, Steven E.,Whitaker, Tony,McBrayer, Tamara R.,Tharnish, Phillip M.,Stuyver, Lieven J.,Schinazi, Raymond F.,Otto, Michael J.,Watanabe, Kyoichi A.
, p. 957 - 960 (2007/10/03)
We recently discovered a novel compound, identified as N 3,5′-cyclo-4-(β-D-ribofuranosyl)-vic-triazolo[4,5-b] pyridinin-5-one, with anti-hepatitis C virus (HCV) activity in vitro. The structure was confirmed by chemical synthesis from 2-hydroxy
Synthesis of N3,5′-cyclo-4-(β-D-ribofuranosyl)-vic- triazolo[4,5-b]pyridin-5-one, a novel compound with anti-hepatitis C virus activity
Wang, Peiyuan,Hollecker, Laurent,Pankiewicz, Krzysztof W.,Patterson, Steven E.,Whitaker, Tony,McBrayer, Tamara R.,Tharnish, Phillip M.,Sidwell, Robert W.,Stuyver, Lieven J.,Otto, Michael J.,Schinazi, Raymond F.,Watanabe, Kyoichi A.
, p. 6100 - 6103 (2007/10/03)
A novel anti-hepatitis C virus (HCV) agent, N3,5′-cyclo-4- (β-D-ribofuranosyl)-vic-triazolo(4,5-b]pyridinin-5-one, was identified, and the structure was confirmed by chemical synthesis from 2-hydroxy-5- nitropyridine.
